Unless I’m mistaken, the only “FDA Approved” CBD drug is Epidiolex. So no, this isn’t currently a true benefit for CVSI, but may help with future rescheduling of CBD products down the line.
CVSI's products can't be Schedule V because CVSI has not developed any drugs yet. CVSI's products are made from natural hemp CBD, so they are natural products or supplements AND NOT DRUGS.
The DEA PR yesterday refers to a newly approved DRUG (Epidiolex) made with CBD. The only thing that is of concern about this DEA rescheduling and CVSI is that Epidiolex main component is CBD.
Epidiolex and CVSI's products are totally different things when seen from a legal stand point. Epidiolex is an FDA approved DRUG. But we all know that the base molecule (CBD) used in Epidiolex is the same that CVSI sells in its more natural form
What i'm trying to say is that we need to separate the two because they are in different legal status. By this I'm not saying that Industrial hemp CBD is illegal. CVSI has been selling it for 5 years in all 50 states and overseas and will continue to do so.
Conclusion:
Epidiolex and CVSI's products must not be compared from a legal stand point. The main takeaway from the DEA rescheduling is that CBD (A Cannabis Sativa L compound) has been recognized by both; the DEA & FDA(unanimously) as a compound with therapeutic value or as a medicine. So much so that they gave the new DRUG a schedule V status; the lowest possible. So this is indirectly beneficial for CVSI and the CBD industry.
News 
Market Data 
Discover 
